ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,972,557 | +0.3% | 598,100 | -0.3% | 0.01% | +71.4% |
| Q1 2023 | $2,964,267 | -20.0% | 600,054 | +1.8% | 0.01% | -70.8% |
| Q4 2022 | $3,706,408 | -45.6% | 589,254 | -6.5% | 0.02% | -70.7% |
| Q3 2022 | $6,808,000 | -0.6% | 630,425 | +4.9% | 0.08% | +7.9% |
| Q2 2022 | $6,851,000 | +7.3% | 601,014 | -14.3% | 0.08% | -23.2% |
| Q1 2022 | $6,387,000 | -39.1% | 701,053 | -0.3% | 0.10% | -38.1% |
| Q4 2021 | $10,495,000 | +2.6% | 703,386 | +76.7% | 0.16% | -28.9% |
| Q3 2021 | $10,230,000 | -2.0% | 398,052 | -0.5% | 0.22% | -1.3% |
| Q2 2021 | $10,436,000 | -26.4% | 400,152 | -0.4% | 0.23% | -32.3% |
| Q1 2021 | $14,177,000 | – | 401,602 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
| Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
| Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
| Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
| Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
| Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
| Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
| Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
| Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |